Cardiac Rhythm Management Devices | Asia Pacific (Supplemental) | 2016 | Market Analysis
The Asia Pacific market for CRM devices will experience robust growth through 2024, driven primarily by an aging population, the increasing prevalence of sedentary lifestyles and unhealthy diets, and the introduction of more advanced technology. Uptake of premium-priced devices such as MRI-compatible devices, leadless pacemakers, and S-ICDs will help mitigate the price erosion.
This Medtech 360 Report provides key market metrics and high-level qualitative commentary for the cardiac rhythm management device market in Asia Pacific, including country-level data for 13 major countries and aggregate data for the rest of Asia Pacific, across a 10-year period
